|
Vaccine Detail
Vaccinia virus DNA vaccine tPA-D8L |
Vaccine Information |
- Vaccine Name: Vaccinia virus DNA vaccine tPA-D8L
- Target Pathogen: Vaccinia virus
- Vaccine Ontology ID: VO_0004487
- Type: DNA vaccine
- Status: Research
- Host Species as Laboratory Animal Model: Mouse
- D8L
gene engineering:
- Type: DNA vaccine construction
- Description: Vector pVax1TM expressed the transmembrane (TM) region and its downstream cytoplasm tail were removed from the wild type D8L gene , and a human tissue plasminogen activator (tPA) leader sequence was added to the N terminus of D8L coding gene (Sakhatskyy et al., 2006).
- Detailed Gene Information: Click Here.
- DNA vaccine plasmid:
- DNA vaccine plasmid name:
- DNA vaccine plasmid VO ID: VO_0005071
- Immunization Route: Gene gun
|
Host Response |
Mouse Response
- Vaccine Immune Response Type: VO_0000286
- Efficacy: Individual outer membrane proteins from intracellular and extracellular virions of vaccinia virus, when delivered in the form of either DNA vaccines or recombinant protein vaccines produced from baculovirus-infected insect cells, were able to protect mice from the vaccinia virus challenge and rhesus macaques from the monkeypox virus challenge (Sakhatskyy et al., 2006).
|
References |
Sakhatskyy et al., 2006: Sakhatskyy P, Wang S, Chou TH, Lu S. Immunogenicity and protection efficacy of monovalent and polyvalent poxvirus vaccines that include the D8 antigen. Virology. 2006; 355(2); 164-174. [PubMed: 16919703].
|
|